ARTICLE | Clinical News
Omega interferon: Began Phase I testing
February 22, 2000 8:00 AM UTC
BioMedicines Inc., Alameda, Calif. Product: Omega interferon Business: Infectious diseases Therapeutic category: Immune stimulation Target: Unknown Description: Recombinant human omega interferon Ind...